TBPH compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

TBPHTheravance Biopharma, Inc.

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

TBPHTheravance Biopharma, Inc.

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TBPH 6

VTRSViatrissupplier

LAZLazardsupplier

GSKGSKcustomer

RPRXRoyalty Pharma Investmentscustomer

2 more · TBPH chain ›

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

TBPHTheravance Biopharma, Inc.

17.03▲+0.02%· post 17.04

Mkt cap$884.2MRevenue$21MQ2 FY26Revenue$107MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

TBPHTheravance Biopharma, Inc.

LLYELI Lilly & Co

17.03▲+0.02%post 17.04

Price

1,360.90▼−0.28%post 1,358.90

$884.2M

Mkt cap

$1.2T

Q2 FY26$21M

Revenue

$24.4BQ3 FY26

FY25$107M

Revenue

$65.2BFY25

TBPH17.03▲+0.02%vsLLY1,360.90▼−0.28%ClosedNov 6 '26